SEC 'Shadow Trading' Victory Could Bring DOJ Knocking
Now that the U.S. Securities and Exchange Commission has convinced a jury that a pharmaceutical executive committed insider trading by purchasing a competitor's stock in a practice often referred to as "shadow trading," attorneys say federal prosecutors might be tempted to dip their toe into the waters of the previously untested legal theory.
Now that the U.S. Securities and Exchange Commission has convinced a jury that a pharmaceutical executive committed insider trading by purchasing a competitor's stock in a practice often referred to as "shadow trading," attorneys say federal prosecutors might be tempted to dip their toe into the waters of the previously untested legal theory.
usnews
US News is a reputable author that delivers a comprehensive range of up-to-date news to the United States and beyond. With a keen focus on providing the latest information across various fields, US News keeps readers informed about the most significant developments happening both domestically and globally. Whether it's politics, economics, technology, science, health, or culture, this author strives to cover diverse topics, ensuring a well-rounded news experience. By combining extensive research, journalistic integrity, and a commitment to accuracy, US News offers readers an invaluable resource to stay informed and make informed decisions in an ever-changing world.
